<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR163">
 <label>163.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Meissner</surname>
    <given-names>HC</given-names>
   </name>
   <name>
    <surname>Long</surname>
    <given-names>SS</given-names>
   </name>
   <collab>American Academy of Pediatrics Committee on Infectious D, Committee on F, Newborn</collab>
  </person-group>
  <article-title>Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections</article-title>
  <source>Pediatrics</source>
  <year>2003</year>
  <volume>112</volume>
  <fpage>1447</fpage>
  <lpage>52</lpage>
  <?supplied-pmid 14654628?>
  <pub-id pub-id-type="pmid">14654628</pub-id>
 </element-citation>
</ref>
